Holen Sie sich die Stockscreener-App
6.54
6.00%
0.37
Vorhandelsmarkt:
6.57
0.03
+0.46%
Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten
Important Notice to Long-Term Shareholders of Five Below, - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Reach Out - ACCESS Newswire
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Important Notice to Long-term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Is Investigating Claims on Your Behalf - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire
Unicycive Therapeutics to Participate in Upcoming Investor Events in December - Black Hills Pioneer
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Unicycive Therapeutics Inc. stock a top momentum playJuly 2025 Reactions & Daily Profit Maximizing Tips - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Unicycive Therapeutics (Nasdaq: UNCY) to join Piper Sandler and Noble investor events - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive The - The National Law Review
Can Unicycive Therapeutics Inc. stock double in next 5 yearsJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - newser.com
Sentiment analysis tools applied to Unicycive Therapeutics Inc.Options Play & Long-Term Capital Growth Ideas - newser.com
Will Unicycive Therapeutics Inc. stock maintain growth storyQuarterly Market Review & Real-Time Sentiment Analysis - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Can Unicycive Therapeutics Inc. stock attract ESG capital inflowsWatch List & Daily Chart Pattern Signals - newser.com
What moving averages say about Unicycive Therapeutics Inc.Weekly Trade Analysis & Consistent Growth Stock Picks - newser.com
What catalysts could drive Unicycive Therapeutics Inc. stock higherEarnings Overview Report & Precise Buy Zone Tips - newser.com
How rising interest rates impact Unicycive Therapeutics Inc. stockWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well - Yahoo Finance
Unicycive Therapeutics, Inc.Common Stock (NQ: UNCY - Markets Financial Content
How Unicycive Therapeutics Inc. stock compares to growth peersJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Can Unicycive Therapeutics Inc. stock hit analyst price targets2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Live market analysis of Unicycive Therapeutics Inc.July 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):